WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search

QJ ANTIINFECTIVES FOR SYSTEMIC USE
QJ05 ANTIVIRALS FOR SYSTEMIC USE
QJ05A DIRECT ACTING ANTIVIRALS
QJ05AR Antivirals for treatment of HIV infections, combinations
QJ05AR01 zidovudine and lamivudine
QJ05AR02 lamivudine and abacavir
QJ05AR03 tenofovir disoproxil and emtricitabine
QJ05AR04 zidovudine, lamivudine and abacavir
QJ05AR05 zidovudine, lamivudine and nevirapine
QJ05AR06 emtricitabine, tenofovir disoproxil and efavirenz
QJ05AR07 stavudine, lamivudine and nevirapine
QJ05AR08 emtricitabine, tenofovir disoproxil and rilpivirine
QJ05AR09 emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
QJ05AR10 lopinavir and ritonavir
QJ05AR11 lamivudine, tenofovir disoproxil and efavirenz
QJ05AR12 lamivudine and tenofovir disoproxil
QJ05AR13 lamivudine, abacavir and dolutegravir
QJ05AR14 darunavir and cobicistat
QJ05AR15 atazanavir and cobicistat
QJ05AR16 lamivudine and raltegravir
QJ05AR17 emtricitabine and tenofovir alafenamide
QJ05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
QJ05AR19 emtricitabine, tenofovir alafenamide and rilpivirine
QJ05AR20 emtricitabine, tenofovir alafenamide and bictegravir
QJ05AR21 dolutegravir and rilpivirine
QJ05AR22 emtricitabine, tenofovir alafenamide, darunavir and cobicistat
QJ05AR23 atazanavir and ritonavir
QJ05AR24 lamivudine, tenofovir disoproxil and doravirine
QJ05AR25 lamivudine and dolutegravir
QJ05AR26 darunavir and ritonavir
QJ05AR27 lamivudine, tenofovir disoproxil and dolutegravir

Last updated: 2022-02-03